Marcelo Rivolta News Today

Kate Fynes, CMC translation consultant at eXmoor Pharma, is full of passion, drive and optimism.

The therapy will build on research that resulted in 40 improved hearing in preclinical tests, researchers said.

A team of scientists and surgeons has for the first time validated a safe surgical access to the central core of the human cochlea, a hollow, spiral-shaped bone found in the inner ear which plays a key role in the sense of hearing.

8.11.2022 - An international research coalition has verified safe surgical access to the central core of the human cochlea for the very first time. The team of surgeons and scientists from the UK, Sweden and Canada, funded by Rinri Therapeutics, has confirmed secure surgical access to the central core of the human cochlea. The research is critical to the first in-human trials of new cell, gene and

SHEFFIELD, England, May 13, 2021 /PRNewswire/ -- Rinri Therapeutics ('Rinri'), a biotechnology company developing a novel cell-based therapy to restore hearing loss, is delighted to announce

May 01 2021 Read 4 Times University of Sheffield spinout company, Rinri Therapeutics, has raised a total of £10 million from existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund, to support the development of its novel stem cell therapy to treat sensorineural hearing loss (SNHL). The company’s underlying technology is based on innovative research into auditory stem cells led by Professor Marcelo Rivolta at the Universit...

Rinri Therapeutics, a Sheffield, England, UK-based biotechnology company developing a novel stem cell therapy to restore hearing, raised a total of £10m in funding. Backers included existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund. The proceeds will support the development of the company’s novel stem cell therapy to reverse sensorineural hearing loss (SNHL). Led by Dr Simon Chandler, CEO, Rinri Therapeutics is a...

Search jobs Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today announces that it has raised a total of £10 million from existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund. The proceeds will support the development of the Company’s novel stem cell therapy to ...

Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss News provided by Share this article Share this article SHEFFIELD, England, April 20, 2021 /PRNewswire/ -- Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today announces that it has raised a total of £10 million from existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioC...

Rinri Therapeutics Appoints Experienced Life Science Executive Nick Higgins as Chairman Extensive private and public company corporate development track record Significant expertise in cell and gene therapy News provided by Share this article Share this article SHEFFIELD, England, Feb. 1, 2021 /PRNewswire/ -- Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, today announces the appointment of Nick Higgins as Chairman of the Board. He takes ov...